An Ultrasonographic Analysis of the Deep Inferior Tendon in the Masseter Muscle: Implications for Botulinum Toxin Injections.
Abstract
(1) Background: With the increasing aesthetic pursuit of facial features, the clinical use of Botulinum Toxin Type A (BoNT-A) injections for masseter hypertrophy has been on the rise. However, due to variations in masseter muscle structure and differences in clinicians' injection techniques, blind injections may lack precision, potentially compromising treatment accuracy and increasing the risk of complications. (2) Objectives: The study aims to use ultrasonography to detail the deep inferior tendon (DIT) within the masseter muscle in a young Chinese cohort, refine its classification, analyze muscle belly thickness and variations across groups, and propose a customized ultrasound-guided BoNT-A injection protocol. (3) Methods: Ultrasound imaging was used to observe the bilateral masseter muscles at rest and during clenching. The features of the DIT were classified from these images, and the thickness of the masseter's distinct bellies associated with the DIT types was measured in both states. (4) Results: The study cohort included 103 participants (27 male, 76 female), with 30 muscles in the normal masseter group and 176 muscles in the hypertrophy group. The DIT was categorized as Type A, B (subtypes B1, B2), and C. The distribution of these types was consistent across normal, hypertrophic, and gender groups, all following the same trend (B > A > C). In hypertrophy, Type B1 showed uniform thickness across masseter bellies, B2 presented with a thinner intermediate belly, and Type C had mainly superficial muscle enlargement. Changes in muscle thickness during clenching were noted but not statistically significant among different bellies. (5) Conclusions: The study evidences individual variation in the DIT, highlighting the importance of precise DIT classification for effective BoNT-A injections. A tailored ultrasound-guided BoNT-A injection strategy based on this classification may enhance safety and efficacy of the therapy.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | masseter
|
scispacy | 1 | ||
| 해부 | tendon
|
scispacy | 1 | ||
| 해부 | masseter muscle
|
scispacy | 1 | ||
| 해부 | bellies
|
scispacy | 1 | ||
| 해부 | muscles
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 합병증 | Deep Inferior
|
scispacy | 1 | ||
| 합병증 | facial
|
scispacy | 1 | ||
| 합병증 | muscle belly
|
scispacy | 1 | ||
| 합병증 | masseter bellies
|
scispacy | 1 | ||
| 합병증 | bellies
|
scispacy | 1 | ||
| 약물 | BoNT-A
→ Botulinum Toxin Type A
|
scispacy | 1 | ||
| 질환 | masseter hypertrophy
|
scispacy | 1 | ||
| 질환 | muscle belly thickness
|
scispacy | 1 | ||
| 질환 | hypertrophy
|
C0020564
Hypertrophy
|
scispacy | 1 | |
| 질환 | muscle enlargement
|
C0236033
Muscle hypertrophy
|
scispacy | 1 | |
| 질환 | Masseter Muscle
|
scispacy | 1 | ||
| 기타 | Toxin Injections
|
scispacy | 1 | ||
| 기타 | Botulinum Toxin Type A
|
scispacy | 1 | ||
| 기타 | BoNT-A
→ Botulinum Toxin Type A
|
scispacy | 1 | ||
| 기타 | bilateral masseter muscles
|
scispacy | 1 | ||
| 기타 | Type A
|
scispacy | 1 | ||
| 기타 | Type B1
|
scispacy | 1 | ||
| 기타 | Type C
|
scispacy | 1 |
MeSH Terms
Masseter Muscle; Humans; Male; Female; Botulinum Toxins, Type A; Hypertrophy; Ultrasonography; Young Adult; Tendons; Injections, Intramuscular; Neuromuscular Agents; Adult; Adolescent
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.